Objective: To evaluate the safety and efficacy of domestic intravenous doxycycline in the treatment of urinary tract infections.Methods:A multicenter,double-blind,randomized controlled clinical trial of intravenous doxycycline and azithromycin on patients with urinary tract infections were conducted.The dosage of doxycycline was 0.2g,once daily,for 5~12d and that of azithromycin was 0.5g,once daily,for 5~12d.Both drugs were given intravenously.Results: In this trial,62 patients were enrolled in doxycycline group,and 60 were enrolled in azithromycin group.The overall efficacy rates and cure rate in trial and control group were 100%,90.32% and 73.33%,95% respectively.There was statistical significant difference in the cure rates between the two groups.The bacterial clearance rates in two groups were 92.5% and 88.9% respectively.The adverse drug reaction rates were7.9% and6.7% respectively.There were no statistical significant differences in the above results between the two groups.The activity of doxycycline against gram-positive organisms was generally higher than that of the other 5 antibacterial agents.Antibacterial activity of doxycycline against gram-negtive bacterium was similar to or stronger than the other antibacterial agents.Conclusion: The results suggest that domestic doxycycline injection with powerful antibacterial activity and wide spectrum is highly effective in treating urinary tract infections.

Objective:To evaluate the safety and efficacy of domestic cefepime in the treatment of lower-respiratory tract bacterial infections.Methods:A double-blind,randomized control clinical trial of intravenous cefepime on patients with lower-respiratory tract bacterial infections were conducted.The regimen of the two groups were 2g,twice daily for 7 to14ds.Both drugs were given intravenously.Results:In this trial,30 patients were enrolled in trial group and other 30 patients were enrolled in control group.The overall efficacy rates and cure rate in trial and control group were 93.33%?63.33% and 96.67%?70% respectively.The bacterial clearance rates were 96% and 100% respectively,and the adverse drug reaction rates were 3.3% and 0%. There was no statistical significant differences in the above results between the two groups.The activity of cefepime against gram-positive organisms was generally higher than that of the other 4 antibacterial agents.Conclusion:The results suggested that demostic cefepime with powerful antibacterial activity and wide spectrum has the same safety and efficacy as imported one in treating lower-respiratory tract bacterial infections.

Objective:To evaluate the safety and efficacy of domestic intravenous gatifloxacin in the treatment of respiratory tract infections.Methods:A multicenter,double-blind,randomized controlled clinical trials of intravenous gatifloxacin and levofloxacin on patients with respiratory tract infections were conducted.The regimen of the two groups were 0.2g,twice daily,7～14days.Both drugs were given intravenously.Results:In this trial,40 patients were enrolled in gatifloxacin group,39 patients were enrolled in levofloxacin group.The overall efficacy rates and cure rate in trial and control group were 95%,65% and 94.87%,64.1% respectively.The bacterial clearance rates were 86.8% and 81.1% respectively in two groups.The adverse drug reaction rates were 7.5% and 10.2% in trial and control group respectively.There were no statistically significant differences in the above results between the two groups.The activity of gatifloxacin against gram-positive organisms was generally higher than that of the other 4 antibacterial agents.Antibacterial activity of gatifloxacin against gram-negtive bacterium was similar or stronger than the other antibacterial agents.Conclusion:The results suggest that domestic gatifloxacin injection with powerful antibacterial activity and wide spectrum is a highly effective and safe broad-spectrum new quinolone in treating respiratory tract infections.

This report emphasizes on US diagnostic characteristics of partly BSTT,including OSteogenic sarcotma in 57 cases,chondrosarcoma in 25 cases, fibrosarcoma in 18 cases, synovial sarcoma in 14 cases, myelogenous neoplasm in 21 cases.metastatic bone ttmlor in 67 cases,giant cell turnor of bone in 52 cases, chordoma in 25 cases,hemangioma In 32 cases,desmoplastic fibroma in 10 cases. Pigrnenled villonodular synovius in 10 cases,and aneurysmal bone cyst in 8 cases, altogether 563 cases. The study firstly presents the application and specific menifestation of US diagnosis in BSTI. In many aspects,US is superor to X-ray, CT and MRI in diagnosing BSTT. It provides a great deal of reliable basis for clinical diagnosis and. Treatment.

Epidermal growth factor receptor (EGFR) tyrosine kinase is over-expressed in numerous human tumors, which plays pivotal roles in cellular signal transduction, and it is involved in a variety of tumor cellular behaviors such as proliferation, metastasis, angiogenesis and so on. Many investigations have indicated that tumor growth can be suppressed by inhibiting EGFR tyrosine kinase activity. Currently, several EGFR tyrosine kinase inhibitors are in clinical trial stage.

Objective: To investigate the effects of lung cancer A549 cells conditioned medium on the proliferative characteristics of umbilical cord blood-mesenchymal stem cells (UCB-MSCs) and the expression of phospho-p38 mitogen activated protein kinase (p-p38MAPK) in UCB-MSCs. Methods: Primary culture system of UCB-MSCs from human umbilical cord blood was established. UCB-MSCs were divided into control (incubated with UCB-MSCs culture medium), low concentration (incubated with 50% A549 cells conditioned medium and 50% UCB-MSCs culture medium) and high concentration (incubated with 100% A549 cells conditioned medium) groups. The abilities of proliferation and migration of UCB-MSCs in each group were detected by MTT method and wound healing assay, respectively. The cell cycle distribution and the expression level of p-p38MAPK protein of UCB-MSCs in each group were analyzed by flow cytometry and Western blotting, respectively. Results: The UCB-MSCs were successfully isolated and cultured. As compared with the control group, the abilities of proliferation and migration of UCB-MSCs in the low concentration and the high concentration groups were increased (P < 0.05). The percentage of the cells in G0/G 1 phase in the high concentration group was lower than that in the control group, while the percentage of the cells in G2/M phase was increased (all P < 0.05). The percentages of the cells in S phase in the low concentration and the high concentration groups were higher than that in the control group (P < 0.05). The expression levels of p-p38MAPK protein of UCB-MSCs in the low concentration and the high concentration groups were up-regulated (P < 0.05). Conclusion: Lung cancer A549 cells conditioned medium can stimulate the proliferation and the migration of UCB-MSCs and up-regulate the expression level of p-p38MAPK protein. Copyright © 2014 by TUMOR.

Objective To isolate and identify differential expression genes associated with multidrug resistance of leukemia . Methods Differential expression genes between leukemia cell line K 562 and resistant cell lines K562/DOX were isolated by using suppression subtractive hybridization (SSH) technique .Total RNA were extracted .cDNA were synthesized and digested by restric-tion enzyme Rsa Ⅰ ,then connected with adopter1 and adopter2R ,and linked with pMD19-T vector .Constructed vectors were trans-ferred into E .coli .Subtracted cDNA library was constructed ,and the positive clones were screened according to base sequences and homologous sequences .The differential expression genes were indentified by comparison analysis of Gene Bank database .Results A total of 220 differential expression genes were sequenced ,including hemoglobin ,ribosomes and mitochondria related genes ,and heat shock factor binding protein 1 (HSPB1) gene and other genes .Conclusion SSH method and molecular cloning technique could be used to construct subtracted cDNA library of differential expression genes between drug resistant and not -resistant leukemia cells , which might be useful for further screening and cloning of differential expression genes of multidrug resistant tumor cells .

Acupuncture Points ; Acupuncture Therapy ; Adolescent ; Adult ; Child ; Combined Modality Therapy ; Exercise Therapy ; Female ; Humans ; Low Back Pain ; therapy ; Male ; Middle Aged ; Young Adult

Objective To investigate the mechanism of cross resistant inducibility of ciprofloxacin and imipenem which led to cross resistance in Pseudomonas aeruginosa in vivo. Methods Cross resistant mutant strains were selected and induced with clinical isolates of P.aeruginosa PA5 susceptible to ciprofloxacin and imipenem by experiment of murine peritonitis. Mutation of DNA gyrase gene, drug uptake and membrance proteins of P.aeruginosa PA5 and its mutants resistant to ciprofloxacin and imipenem were examined. Results Both ciprofloxacin and imipenem could induce resistant strain of P.aeruginosa in experimental murine peritonitis, the cross resistance rates after ciprofloxacin and imipenem challenge were 3.8% and 0.98% respectively. The results of PCR SSCP showed that 3 of six cross resistant of P.aeruginosa strains had gyrA gene mutation. Electrophoresis of outer and inner membrane proteins did not exist any difference between cross resistant strains and their parent strain PA5. Fluorometric assay for ciprofloxacin uptake by bacterial cells indicated that the accumulation of ciprofloxacin in all cross resistant variants decreased to 1/2～1/3 compared with that of PA5. After chanllenge with CCCP, the drug uptake in cross resistance mutants increased to the same level as in PA5. Conclusions The results show that cross resistant strains of P. aeruginosa could be selected and induced in vivo. Active drug efflux is the major factor contributing to the cross resistance of P. aeruginosa to both quinolone and imipenem.